Page last updated: 2024-11-13

alpha-tocotrienol quinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-tocotrienol quinone: reverses visual loss due to retinal ganglion degeneration [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID46184405
CHEMBL ID1812161
SCHEMBL ID503125
SCHEMBL ID14639355
MeSH IDM0577028

Synonyms (40)

Synonym
vatiquinone ,
epi-743
CHEMBL1812161
(r)-alpha-tocotrienol quinone
alpha tocotrienol quinone
alpha-tocotrienol quinone
.alpha.-tocotrienol quinone
6o85fk9i0x ,
2,5-cyclohexadiene-1,4-dione, 2-((3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl)-3,5,6-trimethyl-
vatiquinone [usan:inn]
epi 743
1213269-98-7
unii-6o85fk9i0x
vatiquinone (jan/usan)
D10407
ptc-743
vatiquinone [inn]
2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
vatiquinone [jan]
vatiquinone [usan]
ptc743
SCHEMBL503125
SCHEMBL14639355
DTXSID90153231
CS-0012384
HY-16772
DB11917
epi 743;epi743; vatiquinone; alpha-tocotrienol quinone
BCP21072
2-((r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
LNOVHERIIMJMDG-XZXLULOTSA-N
Q27265220
2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
MS-27922
EX-A5566
2-[(3r,6e,10e)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dion
A937320
bdbm594069
us11584728, compound vatiquinone
AKOS040754343
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (62)

Assay IDTitleYearJournalArticle
AID611206Volume of infusion in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611408Ratio of compound EC50 to co-enzyme Q10 EC50 for cytoprotectant activity in Friedreich ataxia patient fibroblasts2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611310Cmax in mouse brain at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611323Drug level in dog cornea at 300 mg/kg/day, po qd for 7 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611215AUCt in rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611205Clearance in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611333Prolongation of prothrombin time in rat at 100 mg/kg/day, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611314Terminal half life in mouse brain at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611212Bioavailability in fasted rat plasma at 25 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611228AUCt in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611321Drug level in mouse heart at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611227Tmax in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611231Cmax in mouse plasma at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611313AUC (infinity) in mouse brain at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611319Drug level in mouse serum at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611230Terminal half life in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611332Toxicity in rat administered orally once daily for 28 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611322Drug level in dog retina at 300 mg/kg/day, po qd for 7 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611334Prolongation of activated partial thromboplastin time in rat at 100 mg/kg/day, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611217Terminal half life in rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611316Tmax in human plasma at 2 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611225Apparent volume of distribution in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611210Tmax in rat plasma at 25 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611309Terminal half life in mouse plasma at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611219AUCt in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611220AUC (infinity) in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611202AUCt in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611308AUC (infinity) in mouse plasma at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611221Terminal half life in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611312AUCt in mouse brain at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611404Cytoprotectant activity against L-buthionine-(S,R)-sulfoximine-induced cell death in Friedreich ataxia patient fibroblasts assessed as increase of cell viability2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611209Cmax in rat plasma at 25 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611336Prolongation of activated partial thromboplastin time in dog at 100 mg/kg/day, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611223Volume of infusion in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611226Cmax in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611315Cmax in human plasma at 2 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611233AUCt in mouse plasma at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611213Cmax in rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611232Tmax in mouse plasma at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611214Tmax in rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611204Terminal half life in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611406Cytoprotectant activity against L-buthionine-(S,R)-sulfoximine-induced cell death in Leigh syndrome patient fibroblasts assessed as increase of cell viability2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611330Genotoxicity in CHO cells assessed as induction of micronucleus2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611311Tmax in mouse brain at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611324Plasma concentration in dog at 300 mg/kg/day, po qd for 7 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611329Mutagenic activity in Salmonella Typhimurium by Ames test2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611224Volume of distribution at steady state in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611203AUC (infinity) in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611211AUCt in rat plasma at 25 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611207Volume of distribution at steady state in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611218Bioavailability in fed rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611222Clearance in dog plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611410Ratio of compound EC50 to resveratrol EC50 for cytoprotectant activity in Friedreich ataxia patient fibroblasts2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611317Bioavailability in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611335Prolongation of prothrombin time in dog at 100 mg/kg/day, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611229AUC (infinity) in dog plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611216AUC (infinity) in rat plasma at 10 mg/kg, po2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611320Ratio of drug level in mouse heart to serum at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611318Ratio of drug level in mouse brain to serum at 25 mg/kg, ip2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611331Toxicity in dog administered orally once daily for 28 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611208Apparent volume of distribution in rat plasma at 2 mg/kg, iv2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
AID611409Ratio of compound EC50 to idebenone EC50 for cytoprotectant activity in Friedreich ataxia patient fibroblasts2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.75 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (20.00%)5.53%
Reviews4 (26.67%)6.00%
Case Studies2 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other6 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]